Related Experiment Video
Updated: Jan 16, 2026

07:15
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
7.4K
Development and Validation of a Machine Learning-Based Radiomics Model Using Ultrasound Image Features for Prostate
Anli Zhao1, Shunlan Du2, Yanhong Du1
1Ultrasound Department, Dongyang People's Hospital, 322100 Dongyang, Zhejiang, China.
Annali Italiani Di Chirurgia
|January 15, 2026
Summary
A machine learning model using ultrasound radiomics effectively stratifies prostate cancer (PCa) risk. This tool accurately identifies high-risk patients, aiding early diagnosis and personalized treatment decisions for prostate cancer.
Area of Science:
- Radiology
- Oncology
- Machine Learning
Background:
- Prostate cancer (PCa) risk stratification is crucial for effective treatment.
- Current methods rely on PSA levels, Gleason scores, and clinical T stage.
- Novel tools are needed for improved early diagnosis and decision-making.
Purpose of the Study:
- To develop a risk stratification model for PCa using ultrasound imaging and machine learning.
- To provide an effective tool for early PCa diagnosis and personalized treatment.
Main Methods:
- Retrospective analysis of 211 histopathologically confirmed PCa patients.
- Extraction of 135 quantitative radiomic features from ultrasound images.
- Application of machine learning algorithms (SVM, RF, LR) after feature selection.
Main Results:
- The Random Forest (RF) model demonstrated superior performance with high accuracy (90% training, 88% test) and AUC (0.87 training, 0.86 test).
- RF significantly outperformed SVM and Logistic Regression (LR) in AUC comparisons.
- Texture features from wavelet-transformed Gray Level Dependence Matrix (GLDM) were most predictive, emphasizing intratumoral heterogeneity.
Conclusions:
- An RF-based ultrasound radiomics model accurately stratifies PCa risk.
- The model shows remarkable performance in identifying high-risk prostate cancer patients.
- This approach offers a valuable tool for clinical decision-making in PCa management.
Keywords:
machine learningprostate cancerprostate-specific antigenrisk stratificationultrasound imaging
